Works matching IS 26738449 AND DT 2022 AND VI 2 AND IP 3
Results: 4
Why Are We Still Talking about Ivermectin? Editorial Note on Stone et al. Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62% Normalization within 24 Hours.
- Published in:
- Biologics, 2022, v. 2, n. 3, p. 196, doi. 10.3390/biologics2030015
- By:
- Publication type:
- Article
Biosimilars: Harmonizing the Approval Guidelines.
- Published in:
- Biologics, 2022, v. 2, n. 3, p. 171, doi. 10.3390/biologics2030014
- By:
- Publication type:
- Article
Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes.
- Published in:
- 2022
- By:
- Publication type:
- Editorial